Sec. 3. Grants to increase access to contraceptive care
669 words·~3 min read·
/bill/118/hr/9807/ih/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subpart V of part D of title III of the Public Health Service Act ( 42 U.S.C. 256 et seq. ) is amended by adding at the end the following: The Secretary shall carry out a grant program consisting of awarding grants to eligible entities to increase their capacity to provide contraceptive care to individuals seeking to access contraceptive care within or outside of their States of residence. To be eligible to receive a grant under this section, an entity shall— be a hospital, clinic, or other health care facility, university, nonprofit organization, community-based organization, State or local governmental entity, or Tribal government that, through programs, services, or activities that are unbiased and medically and factually accurate— provides or refers for abortion services; or provides unbiased information and counseling about abortion; and be in a State, the District of Columbia, or a commonwealth, territory, or possession of the United States.
In awarding grants under this section, the Secretary shall give priority to eligible entities— in States that, as determined by the Secretary, can demonstrate an increased unmet need for contraceptive services; and which, as of the date of the enactment of this Act, have received a grant under title X of the Public Health Service Act ( 42 U.S.C. 300 et seq. ). A grant under this section may be used for any of the following supplies, equipment, or services related to providing contraceptive care:
Providing patient education on all methods of contraception approved, granted marketing authorization, or cleared under the Federal Food Drug, and Cosmetic Act, or licensed under section 351 of this Act. Purchasing of contraceptive supplies, including emergency contraception. Providing person-centered contraceptive counseling. Based on the outcome of counseling under paragraph (3), as the patient is interested, provide contraception free from coercion, including hormonal contraception medication and devices, barrier contraception, and emergency contraception.
Administering telehealth services, which may include audio, video, and text messaging services. Contracting or hiring clinical and nonclinical support staff, and other relevant health care personnel. Creating and disseminating medically-accurate, culturally- and linguistically-appropriate, accessible educational materials and resources on contraception and contraceptive care for patients. Interpretation and translation services. Contraception referrals and counseling. Follow-up contraceptive care, including the management, evaluation, and changes, including the removal, continuation, and discontinuation, of contraception.
To seek a grant under this section, an eligible entity shall submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require, including a plan for increasing capacity as described in subsection (a). No Federal agency, grantee, subrecipient, or other entity shall, in the course of administering or carrying out any program or activity under this section, act in a manner which has the effect of excluding, limiting, or restricting the participation of any entity that would otherwise be eligible to apply for funds, on the basis of any factor unrelated to the entity’s qualifications to effectively carry out the program or activity.
In this section: The term contraceptive care means education, person-centered counseling, and provision of any method of contraception approved, granted marketing authorization, or cleared under the Federal Food Drug, and Cosmetic Act, or licensed under section 351 of this Act, including emergency contraception. The term contraception means a device, medication, procedure, or behavior that is intended to prevent pregnancy. Such term includes any device, medication, procedure, or behavior listed in the most recently published Birth Control Guide published by the Food and Drug Administration, including— sterilization surgery for women; implantable rods; copper intrauterine devices; intrauterine devices with progestin; injectable contraceptives; oral contraceptives (combined pill); oral contraceptives (progestin only); oral contraceptives (extended or continuous use); contraceptive patch; vaginal contraceptive rings; diaphragms; contraceptive sponges; cervical caps; condoms; spermicides; emergency contraception (levonorgestrel); emergency contraception (ulipristal acetate); and any additional contraceptives approved, granted marketing authorization, or cleared under the Federal Food, Drug, and Cosmetic Act or licensed under section 351 of this Act.
To carry out this section, there is authorized to be appropriated $100,000,000 for each of fiscal years 2025 through 2029. .
Connectionstraces to 2
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources